Similar articles

• Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.

  Laskin CA, Clark CA, Spitzer KA. Laskin CA, et al. Arthritis Rheum. 2004 Mar;50(3):1017-8. doi: 10.1002/art.20210. Arthritis Rheum. 2004. PMID: 15022356 No abstract available.
• Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.

  Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G. Triolo G, et al. Arthritis Rheum. 2003 Mar;48(3):728-31. doi: 10.1002/art.10957. Arthritis Rheum. 2003. PMID: 12632426 Clinical Trial.
• Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.

  Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Noble LS, et al. Fertil Steril. 2005 Mar;83(3):684-90. doi: 10.1016/j.fertnstert.2004.11.002. Fertil Steril. 2005. PMID: 15749498 Clinical Trial.
• Antiphospholipid syndrome in pregnancy.

  Bick RL. Bick RL. Hematol Oncol Clin North Am. 2008 Feb;22(1):107-20, vii. doi: 10.1016/j.hoc.2007.10.008. Hematol Oncol Clin North Am. 2008. PMID: 18207069 Review.
• Obstetric antiphospholipid syndrome: an update on pathophysiology and management.

  Ernest JM, Marshburn PB, Kutteh WH. Ernest JM, et al. Semin Reprod Med. 2011 Nov;29(6):522-39. doi: 10.1055/s-0031-1293206. Epub 2011 Dec 8. Semin Reprod Med. 2011. PMID: 22161465 Review.